Evaluation for NCI Radiation Oncology Branch Clinical Research Protocols
2 other identifiers
observational
903
1 country
1
Brief Summary
Background:
- This protocol will provide a means for screening potential candidates for NCI Radiation Oncology Branch (ROB) protocols. Objectives:
- To permit evaluation of patients referred to the NCI Radiation Oncology Branch in order to identify individuals who will be suitable candidates for Radiation Oncology Branch clinical research protocols. Eligibility:
- Patients suspected of having, or with biopsy proven malignant disease or patients with a benign condition for whom radiotherapy is a potential treatment. Design:
- This is a screening protocol. No investigational treatments will be administered on this protocol.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at P75+ for all trials
Started Sep 2000
Longer than P75 for all trials
1 active site
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
Study Start
First participant enrolled
September 11, 2000
CompletedFirst Submitted
Initial submission to the registry
November 14, 2001
CompletedFirst Posted
Study publicly available on registry
November 15, 2001
CompletedStudy Completion
Last participant's last visit for all outcomes
February 25, 2019
CompletedDecember 12, 2019
February 25, 2019
November 14, 2001
December 11, 2019
Conditions
Keywords
Outcome Measures
Primary Outcomes (1)
To permit evaluation of patients referred to the NCI Radiation Oncology Branch in order to identify individuals who will be suitable candidates for Radiation Oncology Branch clinical research protocols.
Evaluation of patients referred to the NCI Radiation Oncology Branch in order to identify individuals who will be suitable candidates for Radiation Oncology Branch clinical research protocols.
Completion of study
Study Arms (1)
1/Cohort 1
Patients suspected of having, or with biopsy proven malignant disease or patients with a benign condition for whom radiotherapy is a potential treatment
Eligibility Criteria
You may qualify if:
- Patients suspected of having, or with biopsy proven malignant disease or patients with a benign condition for whom radiotherapy is a potential treatment.
- Patient or guardian is able to provide informed consent.
Contact the study team to confirm eligibility.
Sponsors & Collaborators
Study Sites (1)
National Institutes of Health Clinical Center, 9000 Rockville Pike
Bethesda, Maryland, 20892, United States
MeSH Terms
Conditions
Study Officials
- PRINCIPAL INVESTIGATOR
Kevin A Camphausen, M.D.
National Cancer Institute (NCI)
Study Design
- Study Type
- observational
- Observational Model
- CASE ONLY
- Time Perspective
- CROSS SECTIONAL
- Sponsor Type
- NIH
- Responsible Party
- SPONSOR
Study Record Dates
First Submitted
November 14, 2001
First Posted
November 15, 2001
Study Start
September 11, 2000
Study Completion
February 25, 2019
Last Updated
December 12, 2019
Record last verified: 2019-02-25